Helen Rubenstein | Investor Contact |
Barry Greene | Chief Executive Officer |
Steve Kanes | Chief Medical Officer |
Jim Doherty | Chief Research Officer |
Kimi Iguchi | Chief Financial Officer |
Ritu Baral | Cowen and Company |
Thomas Deal | J.P. Morgan |
Paul Matteis | Stifel Financial |
Yasmeen Rahimi | Piper Sandler |
Ami Fadia | Needham & Company |
Andrea Tan | Goldman Sachs |
Laura Chico | Wedbush Securities |
Matt Hagood | Oppenheimer & Co. |
Sumant Kulkarni | Canaccord |
Yatin Suneja | Guggenheim Partners |
Akash Tewari | Jefferies |
Gospel Enyindah-Asonye | Morgan Stanley |
Good morning. Welcome to SAGE Therapeutics Third Quarter 2021 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of SAGE’s website at sagerx.com. This call is the property of SAGE Therapeutics and recording, reproduction, or transmission of this call without the express written consent of SAGE Therapeutics is strictly prohibited.